Mechanistic Plausibility of Unified Bioactive Compound Supplementation in Modulating Inflammation and Cardiovascular Risk: A Hypothesis-Driven Analysis | SciELO Preprints window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-3TT8HYRH0Y'); Open Menu Registrar-se Acesso English Español Ir para o conteúdo principal Ir para o menu de navegação principal Ir para o rodapé Preprints Submissão Áreas do Conhecimento Ciências Agrárias Ciências Biológicas Ciências da Saúde Ciências Exatas e da Terra Ciências Humanas Ciências Sociais Aplicadas Engenharias Linguística, letras e artes Educação em Revista Memórias do Instituto Oswaldo Cruz 47º Encontro Anual da ANPOCS 48º Encontro Anual da ANPOCS 49º Encontro Anual da ANPOCS Sobre Sobre o Servidor Declaração de Privacidade Atualizações do Sistema Contato FAQ Ética no SciELO Preprints Avaliação de preprints Anotações em preprints (via Hypothesis) Avalie um preprint Notícias Início / Ciências da Saúde Preprint / Versão 1 Mechanistic Plausibility of Unified Bioactive Compound Supplementation in Modulating Inflammation and Cardiovascular Risk: A Hypothesis-Driven Analysis article.authors6a0b9a2204e43 Walter Pereira Inovattis Health Science Brazil https://orcid.org/0000-0002-9954-8441 Conceptualization Investigation Methodology Project Administration Validation Visualization DOI: https://doi.org/10.1590/SciELOPreprints.16015 Palavras-chave: Dietary supplements , Cardiovascular health , Polyphenolic compounds, oxidative stress Resumo Background: Chronic low-grade inflammation and oxidative stress are implicated in the pathogenesis of cardiovascular disease and metabolic syndrome. Bioactive compounds derived from botanical sources possess antioxidant and anti-inflammatory properties that may theoretically modulate these pathophysiological processes. However, the mechanistic plausibility of unified supplementation strategies combining multiple bioactive agents remains underexplored. Objective: To present a hypothesis-driven, mechanistic analysis of the potential synergistic effects of a unified bioactive compound formulation—comprising flavonoids, Chlorella vulgaris , green tea catechins, Citrus sinensis anthocyanins, spirulina, psyllium fiber, and fenugreek—on inflammatory pathways, oxidative stress, and cardiovascular risk biomarkers. Methods: This theoretical analysis synthesizes existing evidence from preclinical and clinical studies examining individual bioactive compounds. The proposed mechanistic framework integrates known molecular pathways through which these compounds may influence redox homeostasis, cytokine production, lipid metabolism, and endothelial function. Key Mechanistic Insights: Individual bioactive compounds demonstrate capacity to modulate nuclear factor-κB (NF-κB) signaling, reduce pro-inflammatory cytokine expression (interleukin-6, tumor necrosis factor-α), enhance endogenous antioxidant enzyme activity, improve lipid profiles, and attenuate insulin resistance through multiple molecular pathways. The hypothesis of synergistic or additive effects from unified supplementation is supported by complementary mechanisms of action, including free radical scavenging, immunomodulation, and upregulation of antioxidant response elements. However, direct experimental validation of combined formulations is lacking. Conclusion: The mechanistic rationale for unified bioactive compound supplementation in cardiovascular health is theoretically plausible based on individual compound evidence and complementary pathways. This hypothesis-driven framework provides a foundation for future controlled experimental studies to evaluate safety, bioavailability, potential interactions, and clinical efficacy of combined formulations. Translational application requires rigorous investigation through appropriately designed clinical trials. Downloads Os dados de download ainda não estão disponíveis. Biografia do Autor Walter Pereira, Inovattis Health Science Brazil Walter Pereira Pinto, PhD, is an independent scientist and scientific director specializing in clinical nutrition, metabolic disorders, and translational health science. His research focuses on hypothesis-driven frameworks integrating bioactive compounds, inflammation, oxidative stress, and cardiometabolic regulation. He is affiliated with Performance and Health Science USA Corporation, Inovattis Health Science (Brazil), and Instituto UNA, and develops scientific models aimed at bridging mechanistic plausibility and clinical application. PDF (Inglês) Postado 12/05/2026 Como Citar Mechanistic Plausibility of Unified Bioactive Compound Supplementation in Modulating Inflammation and Cardiovascular Risk: A Hypothesis-Driven Analysis. (2026). Em SciELO Preprints . https://doi.org/10.1590/SciELOPreprints.16015 Formatos de Citação ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver Baixar Citação Endnote/Zotero/Mendeley (RIS) BibTeX Série Ciências da Saúde Copyright (c) 2026 Walter Pereira Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License . .citations-container { overflow-y: auto; overflow-x: hidden; max-height: 1000px; } Avaliações Nenhuma avaliação disponível Plaudit Declaração de dados Os dados de pesquisa estão contidos no próprio manuscrito Aviso de preprints Preprints são manuscritos não avaliados por um periódico científico ou já avaliados mas em processo de publicação. .block_announcements_article:not(:last-child) { padding-bottom: 1.5em; border-bottom: 1px solid; } .block_announcements_article { text-align: left; } .block_announcements #show-all{ font-style: italic; } Notícias SciELO Preprints adota obrigatoriedade de declaração de disponibilização de dados de pesquisa 19 agosto 2025 A partir de 1º de setembro de 2025 os manuscritos submetidos ao SciELO Preprints devem incluir uma declaração de disponibilidade de dados informando sobre onde e como os dados da pesquisa que deram origem ao artigo podem ser acessados. Atualização da Política Editorial e FAQ 21 maio 2025 Todos(as) os(as) autores(as) são solicitados(as) a consultarem a nossa Política Editorial e nossas FAQs antes de submeterem o seu manuscrito. Prêmio Ben Barres Spotlight: Inscrições abertas para 2024 20 maio 2024 Prêmios de até US$ 5.000 estão agora disponíveis para pesquisadores de origens sub-representadas ou países com financiamento limitado para apoiar sua pesquisa, carreira e comunidade. Preprints do SciELO Preprints nas ciências da vida ou biomédicas com pelo menos uma revisão disponível no Sciety são elegíveis! Show all announcements ... SciELO - Scientific Electronic Library Online Rua Dr. Diogo de Faria, 1087 – 9º andar – Vila Clementino 04037-003 São Paulo/SP - Brasil E-mail:
[email protected] app = {"hypothesisHandlerUrl":"https:\/\/preprints.scielo.org\/index.php\/scielo\/$$$call$$$\/plugins\/generic\/hypothesis\/controllers\/hypothesis\/"}; var pkpUsageStats = pkpUsageStats || {};pkpUsageStats.data = pkpUsageStats.data || {};pkpUsageStats.data.Submission = pkpUsageStats.data.Submission || {};pkpUsageStats.data.Submission[16015] = {"data":{"2026":{"5":"17"}},"label":"Todos os downloads","color":"79,181,217","total":17}; var pkpUsageStats = pkpUsageStats || {};pkpUsageStats.locale = pkpUsageStats.locale || {};pkpUsageStats.locale.months = ["Jan","Fev","Mar","Abr","Mai","Jun","Jul","Ago","Set","Out","Nov","Dez"];pkpUsageStats.config = pkpUsageStats.config || {};pkpUsageStats.config.chartType = "bar"; (function (w, d, s, l, i) { w[l] = w[l] || []; var f = d.getElementsByTagName(s)[0], j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src = 'https://www.googletagmanager.com/gtag/js?id=' + i + dl; f.parentNode.insertBefore(j, f); function gtag(){dataLayer.push(arguments)}; gtag('js', new Date()); gtag('config', i); }) (window, document, 'script', 'dataLayer', '3TT8HYRH0Y');
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.